Abstract

CLINICAL STUDY ON CHIRABILVA (Holoptelia integrifolia Planch.) WITH SPECIAL REFERENCE TO ITS ROLE IN HYPERGLYCAEMIA

Surendra Nath*, Kumar Sanjeev, Poonam Sharma, Dwivedi Kamal Nayan

Abstract

All the 50 patients were registered for the study after clinical and laboratory examination as per our protocol out of 50 patients, 30 patients turned up for full follow up. All diagnosed patients were divided into three groups consisting of 10 patients each. Group A consisting of 10 patients which were treated with a standard drug i.e. oral hypoglycemic agents i.e. Gliclazide. Patients of Group B (comprising 10 patients) were treated by only trial drug (water soluble solid extract of Chirabilva), while group C comprising of 10 patients were already taking OHA but were found to have raised blood sugar level, allowed to continue modern treatment in the same dose along with our trial drug. After the initial registration and basal study all patients were randomly recruited in respective trials groups and were given the treatment regularly as per the schedule. The 500 mg capsule of trial drug was prescribed in a dose of 2 capsules daily into two divided dose half an hour before major meals for a period of 3 months, they were advised to visit at monthly interval for assessment of therapeutic response.

Keywords: Chirabilva, oral hypoglycemic agents i.e. Gliclazide. Patients.